Controle do Oxigênio Alvo

O oxigênio é provavelmente a droga mais utilizada em cuidados intensivos neonatais e seu uso não controlado pode levar a consequências danosas ao recém-nascido pré-termo em qualquer momento do período neonatal.

Trecho do Encontro com o especialista Dr. Guilherme Mendes Sant’Anna, médico neonatologista do Montreal Children’s Hospital – McGill University Health Center e Coordenador do Facebook Neonatologia Brasil, realizado em 14/03/2019.

Conteúdo Relacionado

• Encontro com o Especialista – Estratégias para Controle do Oxigênio Alvo
• Postagem – Principais questões sobre Monitoramento do uso de oxigênio na unidade neonatal
• Postagem – Cuidados com o CPAP nasal
• Encontro com o Especialista – Segurança do Paciente em Unidades Neonatais

Referências citadas

• Oxygen-saturation targets and outcomes in extremely preterm infants
  Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM. Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med. 2003 Sep 4;349(10):959-67. PubMed PMID: 12954744.
• Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics. 2000 Feb;105(2):295-310. PubMed PMID: 10654946.
• Target ranges of oxygen saturation in extremely preterm infants.
  SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network, Carlo WA, Finer NN, Walsh MC, et al: Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med 362:1959-1969, 2010.
• Oxygen saturation and outcomes in preterm infants
  BOOST II United Kingdom Collaborative GroupBOOST II Australia Collaborative GroupBOOST II New Zealand Collaborative Group, et al: Oxygen saturation and outcomes in preterm infants. N Engl J Med 368(22):2094-2104, May 30, 2013.
• Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial
  Schmidt B, Whyte RK, Asztalos EV, Moddemann D, Poets C, Rabi Y, Solimano A, Roberts RS; Canadian Oxygen Trial (COT) Group. Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial. JAMA. 2013 May 22;309(20):2111-20. doi: 10.1001/jama.2013.5555. PubMed PMID: 23644995.
• Optimal Oxygenation of Extremely Low Birth Weight Infants: A Meta-Analysis and Systematic Review of the Oxygen Saturation Target Studies.
  Saugstad O.D, Aune D. Optimal Oxygenation of Extremely Low Birth Weight Infants: A Meta-Analysis and Systematic Review of the Oxygen Saturation Target Studies. Neonatology, 2014;105(1):55-63. doi: 10.1159/000356561. Epub 2013 Nov 15. Review. PubMed PMID: 24247112.
• Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration (NeOProM)
  Askie LM, Darlow BA, Finer N, Schmidt B, Stenson B, Tarnow-Mordi W, Davis PG, Carlo WA, Brocklehurst P, Davies LC, Das A, Rich W, Gantz MG, Roberts RS, Whyte RK, Costantini L, Poets C, Asztalos E, Battin M, Halliday HL, Marlow N, Tin W, King A, Juszczak E, Morley CJ, Doyle LW, Gebski V, Hunter KE, Simes RJ; Neonatal Oxygenation Prospective Meta-analysis (NeOProM) Collaboration. Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration. JAMA. 2018 Jun 5;319(21):2190-2201. doi: 10.1001/jama.2018.5725. Erratum in: JAMA. 2018 Jul 17;320(3):308. PubMed PMID: 29872859.

Passos da implantação do Projeto Coala